BioAdaptives, Inc.
BDPT
$0.07
$0.01629.63%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -98.11% | -55.44% | -21.34% | 173.08% | 147.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -98.11% | -55.44% | -21.34% | 173.08% | 147.33% |
| Cost of Revenue | 230.36% | 408.47% | 483.33% | 600.00% | 212.66% |
| Gross Profit | -747.20% | -809.17% | -910.87% | -252.31% | 73.61% |
| SG&A Expenses | 189.29% | 138.56% | 48.14% | 33.91% | -0.53% |
| Depreciation & Amortization | -100.00% | -93.26% | -122.42% | 334.85% | -1.01% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 163.97% | 131.64% | 49.34% | 63.41% | 5.43% |
| Operating Income | -201.62% | -155.13% | -58.69% | -55.58% | 2.59% |
| Income Before Tax | -7.86% | -26.19% | -68.38% | -4.81% | 10.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.86% | -26.19% | -68.38% | -4.81% | 10.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.86% | -26.19% | -68.38% | -4.81% | 10.25% |
| EBIT | -201.62% | -155.13% | -58.69% | -55.58% | 2.59% |
| EBITDA | -268.42% | -218.26% | -93.48% | -34.38% | 10.34% |
| EPS Basic | 12.78% | 50.69% | 59.30% | 86.79% | 90.36% |
| Normalized Basic EPS | -6.59% | 46.70% | 48.89% | 90.48% | 92.36% |
| EPS Diluted | 12.78% | 50.69% | 59.30% | 86.79% | 90.36% |
| Normalized Diluted EPS | -6.59% | 46.70% | 48.89% | 90.48% | 92.36% |
| Average Basic Shares Outstanding | 3.91% | 24.04% | 211.64% | 396.63% | 624.77% |
| Average Diluted Shares Outstanding | 3.91% | 24.04% | 211.64% | 396.63% | 624.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |